NantHealth (NH) Tops Q4 EPS by 1c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- Wall St subdued as markets pause after S&P record high; data, Mideast in focus
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
NantHealth (NH) PT Lowered to $13 at Cantor Fitzgerald Following 4Q
March 31, 2017 10:39 AM EDTCantor Fitzgerald lowered its price target on NantHealth (NASDAQ: NH) to $13.00 (from $15.00) while maintaining a Overweight rating. NH reported 4Q revenues of $24.1 million vs. the FactSet consensus of $27.9 million. Adjusted loss per share was $0.18 vs. loss per share estimates of $0.19.
Management also indicated... More
NantHealth (NH) PT Lowered to $8 at Jefferies Following 4Q
March 31, 2017 7:07 AM EDTJefferies lowered its price target on NantHealth (NASDAQ: NH) to $8.00 (from $16.00) while maintaining a Buy rating. 4Q16 revenues of $24M missed consensus for the second straight period, reflecting shortfalls from both the GPS & HIT sides. HIT revenues missed the model by 13%, as... More
